Pregnancy in women with congenital heart disease: a focus on management and preventing the risk of complications

References

• Curtis SL, Marsden-Williams J, Sullivan C, et al. Current trends in the management of heart disease in pregnancy. Int J Cardiol. 2009;133(1):62–69. doi: 10.1016/j.ijcard.2007.11.084
   PubMed Web of Science ®Google Scholar
• Siu SC, Sermer M, Colman JM, et al. Cardiac Disease in Pregnancy (CARPREG) investigators. Prospective multicenter study of pregnancy outcomes in women with heart disease. Circulation. 2001;104(5):515–521. doi: 10.1161/hc3001.093437
   PubMed Web of Science ®Google Scholar
• American College of Cardiology Cardiovascular Disease in Women Committee and the Cardio-Obstetrics Work Group, Lindley KJ, Bairey Merz CN, et al. Management of women with congenital or inherited cardiovascular disease from pre-conception through pregnancy and postpartum: JACC focus seminar 2/5. J Am Coll Cardiol. 2021;77(14):1778–1798.
   PubMed Web of Science ®Google Scholar
• Bruneau BG. The developmental genetics of congenital heart disease. Nature. 2008;451(7181):943–948. doi: 10.1038/nature06801
   PubMed Web of Science ®Google Scholar
• Goland S, Elkayam U. Pregnancy and Marfan syndrome. Ann Cardiothorac Surg. 2017;6(6):642–653. doi: 10.21037/acs.2017.10.07
   PubMed Web of Science ®Google Scholar
• Roos-Hesselink J, Baris L, Johnson M, et al. Pregnancy outcomes in women with cardiovascular disease: evolving trends over 10 years in the ESC Registry of Pregnancy and Cardiac disease (ROPAC). Eur Heart J. 2019;40(47):3848–3855. doi: 10.1093/eurheartj/ehz136
   PubMed Web of Science ®Google Scholar
• Van Hagen IM, Roos-Hesselink JW. Pregnancy in congenital heart disease: risk prediction and counselling. Heart. 2020;106(23):1853–1861. doi: 10.1136/heartjnl-2019-314702
   PubMed Web of Science ®Google Scholar
• El-Hamamsy I, Zaki M, Stevens LM, et al. Rate of progression and functional significance of aortic root calcification after homograft vs freestyle aortic root replacement. Circulation. 2009;120(11_suppl_1):S269–75. doi: 10.1161/CIRCULATIONAHA.108.843748
   PubMed Web of Science ®Google Scholar
• Musci M, Weng Y, Hubler M, et al. Homograft aortic root replacement in native or prosthetic active infective endocarditis: twenty-year single-center experience. J Thorac Cardiovasc Surg. 2010;139(3):665–673. doi: 10.1016/j.jtcvs.2009.07.026
   PubMed Web of Science ®Google Scholar
• Elkayam U, Bitar F. Valvular heart disease and pregnancy: part II: prosthetic valves. J Am Coll Cardiol. 2005;46(3):403–410. doi: 10.1016/j.jacc.2005.02.087
   PubMed Web of Science ®Google Scholar
• Ginsberg JS, Chan WS, Bates SM, et al. Anticoagulation of pregnant women with mechanical heart valves. Arch Intern Med. 2003;163(6):694–698. doi: 10.1001/archinte.163.6.694
   PubMedGoogle Scholar
• McLintock C. Anticoagulant therapy in pregnant women with mechanical prosthetic heart valves: no easy option. Thromb Res. 2011;127(3):S56–S60. doi: 10.1016/S0049-3848(11)70016-0
   PubMedGoogle Scholar
• Vahanian A, Beyersdorf F, et al. ESC/EACTS Scientific Document Group, 2021 ESC/EACTS Guidelines for the management of valvular heart disease: Developed by the Task Force for the management of valvular heart disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Rev Esp Cardiol (Engl Ed). 2022;75(6):524.
   PubMed Web of Science ®Google Scholar
• Otto CM, Nishimura RA, bonow ro, et al. 2020 acc/aha guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association joint committee on clinical practice guidelines. Circulation. 2021;143(5):e72–e227. doi: 10.1161/CIR.0000000000000923
   PubMed Web of Science ®Google Scholar
• Regitz-Zagrosek V, Roos-Hesselink JW, Bauersachs J, et al. 2018 ESC guidelines for the management of cardiovascular diseases during pregnancy: the task force for the management of cardiovascular diseases during pregnancy of the European society of cardiology (ESC). Eur Heart J. 2018;39(34):3165–3241. doi: 10.1093/eurheartj/ehy340
   PubMed Web of Science ®Google Scholar
• Pijuan-Domenech A, Galian L, Goya M, et al. Cardiac complications during pregnancy are better predicted with the modified who risk score. Int J Cardiol. 2015;195:149–154. doi: 10.1016/j.ijcard.2015.05.076
   PubMed Web of Science ®Google Scholar
• Silversides CK, Grewal J, Mason J, et al. Pregnancy outcomes in women with heart disease: the CARPREG II study. J Am Coll Cardiol. 2018;71(21):2419–2430. doi: 10.1016/j.jacc.2018.02.076
   PubMed Web of Science ®Google Scholar
• Drenthen W, Boersma E, Balci A, et al. Predictors of pregnancy complications in women with congenital heart disease. Eur Heart J. 2010;31(17):2124–2132. doi: 10.1093/eurheartj/ehq200
   PubMed Web of Science ®Google Scholar
• Lu CW, Shih JC, Chen SY, et al. Comparison of 3 Risk estimation methods for predicting cardiac outcomes in pregnant women with congenital heart disease. Circ J. 2015;79(7):1609–1617. doi: 10.1253/circj.CJ-14-1368
   PubMed Web of Science ®Google Scholar
• Meah VL, Cockcroft JR, Backx K, et al. Cardiac output and related haemodynamics during pregnancy: a series of meta-analyses. Heart. 2016;102(7):518–526. doi: 10.1136/heartjnl-2015-308476
   PubMed Web of Science ®Google Scholar
• Boardman H, Ormerod O, Leeson P. Haemodynamic changes in pregnancy: what can we learn from combined datasets? Heart. 2016;102(7):490–491. doi: 10.1136/heartjnl-2015-309166
   PubMed Web of Science ®Google Scholar
• Ruys TP, Cornette J, Roos-Hesselink JW. Pregnancy and delivery in cardiac disease. J Cardiol. 2013;61(2):107–112. doi: 10.1016/j.jjcc.2012.11.001
   PubMed Web of Science ®Google Scholar
• Kim MY, Buyon JP, Guerra MM, et al. Angiogenic factor imbalance early in pregnancy predicts adverse outcomes in patients with lupus and antiphospholipid antibodies: results of the PROMISSE study. Am J Obstet Gynecol. 2016;214(1):.e108.1–.e108.14. doi: 10.1016/j.ajog.2015.09.066
   Web of Science ®Google Scholar
• Lewey J, Andrade L, Levine LD. Valvular heart disease in pregnancy. Cardiol Clin. 2021;39(1):151–161. doi: 10.1016/j.ccl.2020.09.010
   PubMed Web of Science ®Google Scholar
• Anthony J, Osman A, Sani MU. Valvular heart disease in pregnancy. Cardiovasc J Afr. 2016;27(2):111–118. doi: 10.5830/CVJA-2016-052
   PubMed Web of Science ®Google Scholar
• Shapero KS, Nauriyal V, Megli C, et al. Management of infective endocarditis in pregnancy by a multidisciplinary team: a case series. Ther Adv Infect Dis. 2022;9:20499361221080644. doi: 10.1177/20499361221080644
   Web of Science ®Google Scholar
• Greer IA. Thrombosis in pregnancy: maternal and fetal issues. Lancet. 1999;353(9160):1258–1265. doi: 10.1016/S0140-6736(98)10265-9
   PubMed Web of Science ®Google Scholar
• Kujovich JL. Hormones and pregnancy: thromboembolic risks for women. Br J Haematol. 2004;126(4):443–454. doi: 10.1111/j.1365-2141.2004.05041.x
   PubMed Web of Science ®Google Scholar
• Heit JA, Kobbervig CE, James AH, et al. Trends in the incidence of venous thromboembolism during pregnancy or postpartum: a 30-year population-based study. Ann Intern Med. 2005;143(10):697–06. doi: 10.7326/0003-4819-143-10-200511150-00006
   PubMed Web of Science ®Google Scholar
• Curry RA, Gelson E, Swan L, et al. Marfan syndrome and pregnancy: Maternal and neonatal outcomes. BJOG: Int J Obstet Gy. 2014;121(5):610–617. doi: 10.1111/1471-0528.12515
   PubMed Web of Science ®Google Scholar
• Carlson M, Airhart N, Lopez L, et al. Moderate aortic enlargement and bicuspid aortic valve are associated with aortic dissection in turner syndrome: Report of the international Turner syndrome aortic dissection registry. Circulation. 2012;126(18):2220–2226. doi: 10.1161/CIRCULATIONAHA.111.088633
   PubMed Web of Science ®Google Scholar
• Nienaber CA, Fattori R, Mehta RH, et al. Gender related differences in acute aortic dissection. Circulation. 2004;109(24):3014–3021. doi: 10.1161/01.CIR.0000130644.78677.2C
   PubMed Web of Science ®Google Scholar
• Pieper PG. Use of medication for cardiovascular disease during pregnancy. Nat Rev Cardiol. 2015;12(12):718–729. doi: 10.1038/nrcardio.2015.172
   PubMed Web of Science ®Google Scholar
• Roos-Hesselink JW, Cornette J, Sliwa K, et al. Contraception and cardiovascular disease. Eur Heart J. 2015;36(27):1728–1734. doi: 10.1093/eurheartj/ehv141
   PubMed Web of Science ®Google Scholar
• Lidegaard O, Lokkegaard E, Svendsen AL, et al. Hormonal contraception and risk of venous thromboembolism: National follow-up study. BMJ. 2009;339(aug13 2):b2890. doi: 10.1136/bmj.b2890
   PubMedGoogle Scholar
• Martinez-Portilla RJ, Poon LC, Benitez-Quintanilla L, et al. Incidence of pre-eclampsia and other perinatal complications among pregnant women with congenital heart disease: systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2021 Oct;58(4):519–528.
   PubMed Web of Science ®Google Scholar
• Lammers AE, Diller GP, Lober R, et al. Maternal and neonatal complications in women with congenital heart disease: a nationwide analysis. Eur Heart J. 2021;42(41):4252–4260. doi: 10.1093/eurheartj/ehab571
   PubMed Web of Science ®Google Scholar
• Sliwa K, Azibani F, Johnson MR, et al. Effectiveness of implanted cardiac rhythm recorders with electrocardiographic monitoring for detecting arrhythmias in pregnant women with symptomatic arrhythmia and/or structural heart disease: a randomized clinical trial. JAMA Cardiol. 2020;5(4):458–463. doi: 10.1001/jamacardio.2019.5963
   PubMed Web of Science ®Google Scholar
• Kirby A, Curtis E, Hlohovsky S, et al. Pregnancy outcomes and risk evaluation in a contemporary adult congenital heart disease cohort. Heart Lung Circ. 2021;30(9):1364–1372. doi: 10.1016/j.hlc.2021.03.005
   PubMed Web of Science ®Google Scholar
• Yap SC, Drenthen W, Meijboom FJ, et al. Comparison of pregnancy outcomes in women with repaired versus unrepaired atrial septal defect. BJOG. 2009;116(12):1593–1601. doi: 10.1111/j.1471-0528.2009.02301.x
   PubMed Web of Science ®Google Scholar
• Mendelson MA. Pregnancy in women with left-to-right cardiac shunts: Any risk? Int J Cardiol Congenit Heart Dis. 2021;5:100209. doi: 10.1016/j.ijcchd.2021.100209
   Google Scholar
• Silversides CK, Colman JM, Sermer M, et al. Early and intermediate-term outcomes of pregnancy with congenital aortic stenosis. Am J Cardiol. 2003;91(11):1386–1389. doi: 10.1016/S0002-9149(03)00340-0
   PubMed Web of Science ®Google Scholar
• Elkayam U, Bitar F. Valvular heart disease and pregnancy part I: native valves. J Am Coll Cardiol. 2005;46(2):223–230. doi: 10.1016/j.jacc.2005.02.085
   PubMed Web of Science ®Google Scholar
• Samiei N, Amirsardari M, Rezaei Y, et al. Echocardiographic evaluation of hemodynamic changes in left-sided heart valves in pregnant women with valvular heart disease. Am J Cardiol. 2016;118(7):1046–1052. doi: 10.1016/j.amjcard.2016.07.005
   PubMed Web of Science ®Google Scholar
• Zentner D, Kotevski A, King I, et al. Fertility and pregnancy in the Fontan population. Int J Cardiol. 2016;208:97–01. doi: 10.1016/j.ijcard.2016.01.180
   PubMed Web of Science ®Google Scholar
• Canobbio MM, Mair DD, van der Velde M, et al. Pregnancy outcomes after the Fontan repair. J Am Coll Cardiol. 1996;28(3):763–767. doi: 10.1016/0735-1097(96)00234-3
   PubMed Web of Science ®Google Scholar
• Lao TT, Sermer M, Colman JM. Pregnancy after the Fontan procedure for tricuspid atresia. A case report. J Reprod Med. 1996;41(4):287–290.
   PubMed Web of Science ®Google Scholar
• Gnanaraj JP, Anne Princy S. Surendran Anju, et al on behalf of the M-PAC investigators. Pregnancy outcomes in women with heart disease: the Madras Medical College Pregnancy and Cardiac (M-PAC) Registry from India. Eur Heart J. 2023;1–12.
   PubMed Web of Science ®Google Scholar
• Jolien WR-H, Van der Zande JA, Johnson MR. Pregnancy outcomes in women with heart disease: how to improve? Eur Heart J. 2023;1–3.
   PubMedGoogle Scholar
• Pierpont ME, Basson CT, Benson DW Jr, et al. Genetic basis for congenital heart defects: Current knowledge. Circulation. 2007;115(23):3015–3038. doi: 10.1161/CIRCULATIONAHA.106.183056
   PubMed Web of Science ®Google Scholar
• Sayama S, Takeda N, Fujii T, et al. Peripartum type B aortic dissection in patients with Marfan syndrome who underwent aortic root replacement: a case series study. BJOG. 2018 Mar;125(4):487–493.
   PubMedGoogle Scholar
• Song S, Lu L, Li L, et al. Antepartum acute Stanford type a aortic dissection: a case report and literature review. J Cardiothorac Surg. 2022;17(1):73. doi: 10.1186/s13019-022-01817-7
   PubMed Web of Science ®Google Scholar
• Meccanici F, Gökalp AL, Thijssen CGE, et al. Male-female differences in acute thoracic aortic dissection: a systematic review and meta-analysis. Interact Cardiovasc Thorac Surg. 2022;34(4):616–627. doi: 10.1093/icvts/ivab270
   PubMed Web of Science ®Google Scholar
• Baris L, Ladouceur M, Johnson MR, et al. Pregnancy in Tetralogy of Fallot data from the ESC EORP ROPAC registry. Int J Cardiol Congenit Heart Dis. 2021;2:100059. doi: 10.1016/j.ijcchd.2020.100059
   Google Scholar
• Wang K, Xin J, Wang X, et al. Pregnancy outcomes among 31 patients with tetralogy of Fallot, a retrospective study. Bmc Pregnancy Childbirth. 2019;19(1):486. doi: 10.1186/s12884-019-2630-y
   PubMed Web of Science ®Google Scholar
• Balci A, Drenthen W, Mulder BJ, et al. Pregnancy in women with corrected tetralogy of Fallot: occurrence and predictors of adverse events. Am Heart J. 2011;161(2):307–313. doi: 10.1016/j.ahj.2010.10.027
   PubMed Web of Science ®Google Scholar
• Fahed AC, Gelb BD, Seidman JG, et al. Genetics of congenital heart disease: the glass half empty. Circ Res. 2013;112(4):707–720. doi: 10.1161/CIRCRESAHA.112.300853
   PubMed Web of Science ®Google Scholar
• Tutarel O, Ramlakhan KP, Baris L, et al. ROPAC (Registry of Pregnancy and Cardiac Disease) Investigators Group. Pregnancy outcomes in women after arterial switch operation for transposition of the great arteries: results from ROPAC (Registry of Pregnancy and Cardiac Disease) of the European society of cardiology EURObservational research programme. J Am Heart Assoc. 2021 5;10(1):e018176. doi: 10.1161/JAHA.120.018176
   PubMed Web of Science ®Google Scholar
• ROPAC Investigators Group, Tutarel O, Baris L, et al. Pregnancy outcomes in women with a systemic right ventricle and transposition of the great arteries results from the ESC-EORP Registry of Pregnancy and Cardiac disease (ROPAC). Heart. 2022;108(2):117–123.
   PubMed Web of Science ®Google Scholar
• Sliwa K, van Hagen IM, Budts W, et al. ROPAC investigators. Society of cardiology pulmonary hypertension and pregnancy outcomes: data from the Registry of Pregnancy and Cardiac Disease (ROPAC) of the European. Eur J Heart Fail. 2016;18(9):1119–1128. doi: 10.1002/ejhf.594
   PubMed Web of Science ®Google Scholar
• Zhang Q, Zhu F, Shi G, et al. Maternal outcomes among pregnant women with congenital heart disease-associated pulmonary hypertension. Circulation. 2023;147(7):549–561. doi: 10.1161/CIRCULATIONAHA.122.057987
   PubMed Web of Science ®Google Scholar
• Presbitero P, Somerville J, Stone S, et al. Pregnancy in cyanotic congenital heart disease. Outcome of mother and fetus. Circulation. 1994;89(6):2673–2676. doi: 10.1161/01.CIR.89.6.2673
   PubMed Web of Science ®Google Scholar
• Economy KE, Valente AM. Mechanical heart valves in pregnancy: a sticky business. Circulation. 2015;132(2):79–81. doi: 10.1161/CIRCULATIONAHA.115.017349
   PubMed Web of Science ®Google Scholar
• Schaefer C, Hannemann D, Meister R, et al. Vitamin K antagonists and pregnancy outcome. A multi-centre prospective study. Thromb Haemost. 2006 Jun;95(6):949–957.
   PubMed Web of Science ®Google Scholar
• Hassounaa A, Allam H. Limited dose warfarin throughout pregnancy in patients with mechanical heart valve prosthesis: a meta-analysis. Interact Cardiovasc Thorac Surg. 2014;18(6):797–06. doi: 10.1093/icvts/ivu009
   PubMed Web of Science ®Google Scholar
• Xu Z, Fan J, Luo X, et al. Anticoagulation regimens during pregnancy in patients with mechanical heart valves: A systematic review and meta-analysis. Can J Cardiol. 2016;32(10):1248. e1–1248.e9. doi: 10.1016/j.cjca.2015.11.005
   PubMed Web of Science ®Google Scholar
• Stephenson ML, Serra AE, Neeper JM, et al. A randomized controlled trial of differing doses of postcesarean enoxaparin thromboprophylaxis in obese women. J Perinatol. 2016;36(2):95–99. doi: 10.1038/jp.2015.130
   PubMed Web of Science ®Google Scholar
• Shapiro NL, Kominiarek MA, Nutescu EA, et al. Dosing and monitoring of low-molecular-weight heparin in high-risk pregnancy: single-center experience. Pharmacotherapy. 2011;31(7):678–685. doi: 10.1592/phco.31.7.678
   PubMed Web of Science ®Google Scholar
• Ruys TPE, Roos-Hesselink JW, Pijuan-Domènech A, et al. Is a planned caesarean section in women with cardiac disease beneficial? Heart. 2015;101(7):530–536. doi: 10.1136/heartjnl-2014-306497
   PubMed Web of Science ®Google Scholar
• San-Frutos L, Engels V, Zapardiel I, et al. Hemodynamic changes during pregnancy and postpartum: a prospective study using thoracic electrical bioimpedance. J Matern Fetal Neonatal Med. 2011;24(11):1333–1340. doi: 10.3109/14767058.2011.556203
   PubMed Web of Science ®Google Scholar
• Davis Melinda B, Arendt K, Bello NA, et al. Team-based care of women with cardiovascular disease from pre-conception through pregnancy and postpartum. J Am Coll Cardiol. 2021;77(14):1763–1777. doi: 10.1016/j.jacc.2021.02.033
   PubMed Web of Science ®Google Scholar
• Lima F, Nie L, Yang J, et al. Postpartum cardiovascular outcomes among women with heart disease from a nationwide study. Am J Cardiol. 2019;123(12):2006–2014. doi: 10.1016/j.amjcard.2019.03.012
   PubMed Web of Science ®Google Scholar